Literature DB >> 16959899

A CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursor.

Saskia J A M Santegoets1, Allan J Masterson, Pieter C van der Sluis, Sinéad M Lougheed, Donna M Fluitsma, Alfons J M van den Eertwegh, Herbert M Pinedo, Rik J Scheper, Tanja D de Gruijl.   

Abstract

The study of early events in dendritic cell (DC) differentiation is hampered by the lack of homogeneous primary cell systems that allow the study of cytokine-driven, transitional DC differentiation steps. The CD34(+) acute myeloid leukemia cell line MUTZ-3 displays a unique ability to differentiate into interstitial DC (IDC) and Langerhans cells (LC) in a cytokine-dependent manner. Phenotypic characterization revealed MUTZ-3 to consist of three distinct subpopulations. Small CD34(+)CD14(-)CD11b(-) progenitors constitute the proliferative compartment of the cell line with the ability to differentiate through a CD34(-)CD14(-)CD11b(+) stage to ultimately give rise to a morphologically large, nonproliferating CD14(+)CD11b(hi) progeny. These CD14(+)CD11b(hi) cells were identified as common, immediate myeloid DC precursors with the ability to differentiate into LC and IDC, exhibiting characteristic and mutually exclusive expression of Langerin and DC-specific ICAM-grabbing nonintegrin, respectively. The identity of the MUTZ-3-derived LC subset was confirmed further by the presence of Birbeck granules. We conclude that the MUTZ-3 cell line provides a ready and continuous supply of common myeloid precursors, which should facilitate further study of the ontogeny of myeloid DC lineages.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959899     DOI: 10.1189/jlb.0206111

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  25 in total

1.  The plasticity and potential of leukemia cell lines to differentiate into dendritic cells.

Authors:  Qingwei Guo; Leling Zhang; Fu Li; Guosheng Jiang
Journal:  Oncol Lett       Date:  2012-07-25       Impact factor: 2.967

Review 2.  The characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseases.

Authors:  Changjin Yuan; Guanhua Song; Guosheng Jiang
Journal:  Intractable Rare Dis Res       Date:  2012-05

3.  Microdevice integrating innate and adaptive immune responses associated with antigen presentation by dendritic cells.

Authors:  Bhaskar Mitra; Rohit Jindal; Serom Lee; Dave Xu Dong; Lulu Li; Nripen Sharma; Tim Maguire; Rene Schloss; Martin L Yarmush
Journal:  RSC Adv       Date:  2013-07-05       Impact factor: 3.361

4.  An epithelial organoid model with Langerhans cells for assessing virus-host interactions.

Authors:  Robert Jackson; Statton Eade; Ingeborg Zehbe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

5.  A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration.

Authors:  Rieneke van de Ven; George L Scheffer; Anneke W Reurs; Jelle J Lindenberg; Ruud Oerlemans; Gerrit Jansen; Jean-Pierre Gillet; Joel N Glasgow; Alexander Pereboev; David T Curiel; Rik J Scheper; Tanja D de Gruijl
Journal:  Blood       Date:  2008-07-14       Impact factor: 22.113

6.  Transcriptional and functional defects of dendritic cells derived from the MUTZ-3 leukaemia line.

Authors:  Jane Rasaiyaah; Mahdad Noursadeghi; Paul Kellam; Benjamin Chain
Journal:  Immunology       Date:  2009-07       Impact factor: 7.397

7.  Perspectives on Non-Animal Alternatives for Assessing Sensitization Potential in Allergic Contact Dermatitis.

Authors:  Nripen S Sharma; Rohit Jindal; Bhaskar Mitra; Serom Lee; Lulu Li; Tim J Maguire; Rene Schloss; Martin L Yarmush
Journal:  Cell Mol Bioeng       Date:  2012-03       Impact factor: 2.321

8.  Selective transduction of mature DC in human skin and lymph nodes by CD80/CD86-targeted fiber-modified adenovirus-5/3.

Authors:  Rieneke van de Ven; Jelle J Lindenberg; Dinja Oosterhoff; M Petrousjka van den Tol; Rodney A Rosalia; Miho Murakami; Maaike Everts; George L Scheffer; Rik J Scheper; Tanja D de Gruijl; David T Curiel
Journal:  J Immunother       Date:  2009 Nov-Dec       Impact factor: 4.456

9.  A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests.

Authors:  Henrik Johansson; Malin Lindstedt; Ann-Sofie Albrekt; Carl A K Borrebaeck
Journal:  BMC Genomics       Date:  2011-08-08       Impact factor: 3.969

10.  Priming of PRAME- and WT1-specific CD8+ T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy.

Authors:  Willemijn van den Ancker; Jurjen M Ruben; Theresia M Westers; Dewi Wulandari; Hetty J Bontkes; Erik Hooijberg; Anita G M Stam; Saskia J A M Santegoets; Gert J Ossenkoppele; Tanja de Gruijl; Arjan van de Loosdrecht
Journal:  Oncoimmunology       Date:  2013-04-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.